Propel Bio Management, LLC

Q2 2026 13F-HR Holdings

Location
Los Angeles, CA
Holdings as of
6/30/2026
Date filed
8/13/2026
Form type
13F-HR
Num holdings
29
Total value ($000)
$191,086
Net value change ($000)
+32,427 (20.4%)
New positions
4
Sold out positions
13
Turnover %
20.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ACHV 14,973 131.7%
CORT 5,847 97.1%
ARTV 5,805 611.1%
IMMUNIC INC 4,996 NEW
MIST 4,874 95.9%
CMPS 3,991 96.9%
PALI 3,400 170.3%
AQST 3,049 103.3%
KYTX 2,283 40.9%
SCYNEXIS INC 2,212 NEW
Top Reduces (Value $000, Stocks/ETFs)
VOR -5,587 -100.0%
VRDN -4,088 -100.0%
OCS -3,279 -100.0%
TRVI -2,647 -100.0%
IMUX -2,620 -100.0%
CHRS -2,413 -100.0%
KLRS -1,721 -100.0%
QURE -1,713 -100.0%
NUVB -1,413 -100.0%
EVMN -1,280 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type